Research Grants show all

NIH12

Patents show all

244Applications97Issued

Clinical Trials show all

13Phase 212Phase 12N/A1Other

SEC Filings show all

8-K7010-Q2010-K7D3S-11

SEC Form D Funding Events

DateOfferedSoldType
2010-12-23$15,000,000$8,100,000Debt, Option to Acquire, Security to be Acquired
2009-10-26$30,000,002$26,645,523Equity
2003-05-21UnknownUnknownOther (Paper Filing)

Key Executives

  • P. Ron Ellis
    Executive Officer, Director
  • John C. Aplin
    Director
  • Douglas B. Bailey
    Director
  • Keith Brauer
    Director
  • Jack Clawson
    Director
  • Ann F. Hanham
    Director
  • Philip S. Low
    Director
  • Fred A. Middleton
    Director
  • Mike Sherman
    Executive Officer
  • Douglas G. Bailey
    Director
  • Keith E. Brauer
    Director
  • John C. Clawson
    Director
  • Michael A. Sherman
    Executive Officer
  • James S. Shannon
    Director